BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Singapore Approves Pfizer-BioNTech’s LP.8.1-Adapted COVID-19 Vaccine for Individuals Aged Six Months and Older

The updated COVID-19 vaccine is expected to be available in Singapore at selected polyclinics and private general practitioner (GP) clinic...

October 27, 2025 | News

SK Bioscience Files Clinical Trial Application in Australia for GBP511 Universal Coronavirus Vaccine

Candidate designed to protect against COVID-19 variants and broader Sarbecoviruses Phase 1/2 study to enroll ~500 healthy adults, with topline results e...

October 16, 2025 | News

South Korea’s Celltrion Secures U.S. FDA Approval to Expand AVTOZMA® IV for Cytokine Release Syndrome in Adults and Children

Approval of AVTOZMA® (tocilizumab-anoh) intravenous infusion expands label to include treatment of adults and pediatric patients aged 2 years an...

August 07, 2025 | News

LUCA AICELL Launches Drug-Free Nasal Spray to Shield Against COVID-19, Influenza, and Mycoplasma Pneumonia

As respiratory illnesses like COVID-19, influenza, and Mycoplasma pneumonia continue to spread, the need for safe, non-pharmaceutical prevention optio...

June 30, 2025 | News

SK Bioscience to Lead Korea’s Avian Influenza Vaccine Development Under KRW 5.25B Pandemic Preparedness Program

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that it has bee...

May 07, 2025 | News

Syensqo and Emulseo Partner to Advance Microfluidic Innovations in Healthcare

Syensqo, a leading specialty chemicals company, is pleased to announce a strategic partnership with Emulseo, a French company specialized in formulations f...

February 21, 2025 | News

Thermo Fisher Secures FDA Clearance for Multiplex Test Targeting Four Major Respiratory Viruses

Thermo Fisher Scientific has announced the 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Applied Biosystems™ TaqPath&trad...

February 10, 2025 | News

DIOSynVax Introduces New Influenza Vaccine Portfolio and Advisory Board to Tackle Global Pandemic Threats

DIOSynVax, a clinical-stage biotechnology company at the forefront of developing innovative, broadly protective vaccines, built on the safety demonstrated ...

January 09, 2025 | News

Thermo Fisher Concludes Successful Bioprocess World Tour 2024 in APJ, Reigniting Industry Momentum Post-COVID

Thermo Fisher Scientific is proud to announce the successful conclusion of its highly anticipated Bioprocess World Tour 2024 in the Asia-Pacific and Japan ...

October 23, 2024 | News

Waters Introduces Innovative Tools to Simplify and Accelerate RNA Therapeutic Development

Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA vacci...

October 11, 2024 | News

Hyundai Bioscience Partners with UC San Diego for Pioneering Long-COVID Clinical Trial of Antiviral Xafty®

Hyundai Bioscience USA announced that it has signed an MOU with the University of California San Diego (UCSD) to conduct an invest...

September 18, 2024 | News

Hyundai Bioscience Announces XAFTY®: A Breakthrough Broad-Spectrum Antiviral for COVID-19, Mpox, and Dengue

Hyundai Bioscience presents development updates of its broad-spectrum antiviral at the "Disease Prevention and Control Summit 2024" held in Philadel...

September 12, 2024 | News

Hyundai Bioscience Advances Xafty® as Sole Oral COVID-19 Treatment for High-Risk Patients Ineligible for Paxlovid®

"Xafty® can be the only oral COVID-19 treatment that can be prescribed to high-risk group patients who cannot take Paxlovid®" "While maintaining...

August 29, 2024 | News

Pfizer and BioNTech Announce Mixed Results from Phase 3 Trial of Combination mRNA Vaccine for Influenza and COVID-19

Pfizer Inc. and BioNTech SE announced top-line results from their Phase 3 clinical trial to evaluate the companies’ combined mRNA vac...

August 19, 2024 | News

Stay Connected